Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs

Source :: Cancer Gene Therapy Week. January 25, 2021, 73
Publication Year :: 2021
Abstract: 2021 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Myeloid Therapeutics, Inc., a company harnessing and reprogramming myeloid cells to treat cancers, [...]

Subjects :: MaxCyte Inc. -- Licensing agreements
T cells
Biotechnology industry -- Licensing agreements
Non-Hodgkin's lymphomas
Cancer -- Care and treatment -- Genetic aspects
Biological products -- Health aspects
Biomedical engineering
Company licensing agreement
Biotechnology industry
Health
Science and technology

Tools